Fate Therapeutics (FATE) announced the appointment of Kamal Adawi, M.S., M.B.A., to the role of Chief Financial Officer, CFO, effective October 20, 2025. Adawi brings to the Company more than 20 years of financial leadership experience in the life sciences industry.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential